Cytochrome P-450 CYP2A6 Inhibitors (weak)
DBCAT003897Pharmacologic class
A DrugBank category of 6 drugs. 6 of them are approved.
- Also known as
- CYP2A6 Inhibitors (weak) · Weak CYP2A6 inhibitors
What you can answer from here — as of May 20, 2021
Which targets do Cytochrome P-450 CYP2A6 Inhibitors (weak) share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account